Seroma is an Expected Consequence and not a Complication of MammoSite Brachytherapy

Author:

Patel Priti S.,Yan Weisi,Trichter Sam,Sabbas Albert,Rosenblatt Ruth,Drotman Michele B.,Swistel Alexander,Clifford Chao K. S.,Nori Dattatreyudu,Hayes Mary Katherine

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Reference19 articles.

1. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy;Keisch;Int J Radiat Oncol Biol Phys,2003

2. Thirty-nine month results with the MammoSite brachytherapy applicator: details regarding cosmesis, toxicity and local control in partial breast irradiation;Keisch;Int J Radiat Oncol Biol Phys,2005

3. Four year clinical update from the American Society of Breast surgeons MammoSite brachytherapy trial;Nelson;Am J Surg,2009

4. NSABP PROTOCOL B-39, RTOG PROTOCOL 0413; A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, II, Breast Cancer http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0413

5. The Surgeon’s Role in Breast Brachytherapy;Beitsch;Breast J,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3